Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma-Reference-Cited by-同舟云学术

Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma

Published:2018-11 Issue:2 Volume:289 Page:564-567
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Cheshire Sophie C.¹^ORCID,Board Ruth E.¹,Lewis Alexandra R.¹,Gudur Laxminarayan D.¹,Dobson Michael J.¹

Affiliation:

1. From the Departments of Radiology (S.C.C., M.J.D.), Oncology (R.E.B., A.R.L.), and Cellular Pathology (L.D.G.), Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Sharoe Green Lane North, Fulwood, Preston, PR2 9HT, England.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2018180572

Reference9 articles.

1. Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports

2. Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

3. Pembrolizumab-associated sarcoidosis

4. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

5. Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcoid-like reaction and hypothyroidism induced by PD-1 inhibitor treatment in metastatic renal cell carcinoma: a case report and literature review;BMC Pulmonary Medicine;2024-03-08

2. Sarcoid-like reaction in malignant melanoma exacerbated with pembrolizumab therapy case report;Heliyon;2024-01

3. Sarcoidlike Reaction Involving Bone Marrow in Patient Receiving Immune Checkpoint Inhibitor Therapy;American Journal of Roentgenology;2023-08

4. Sarcoid-Like Reaction in a Patient with Newly Diagnosed Prostate Cancer;Radiopaedia.org;2023-06-22

5. Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review;Cancers;2023-04-29